Adaptive Biotechnologies Corporation (ADPT) stock analysis

ADPT · Adaptive Biotechnologies Corporation

Latest recorded price: USD 27.87

Sector and industry: Healthcare · Diagnostics & Research

Fiscal 2025 figures: revenue growth 14.3%, free cash flow margin -17.7%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare